Researchers at BC Cancer, the University of British Columbia (UBC), Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer—cancer-like mutations appearing in the cells of healthy women.
Dr. Poul Sorensen is the recipient of the 2024 Doctors of BC Terry Fox Medal, a prestigious award recognizing outstanding individuals who have achieved success in clinical practice, research and/or teaching to advance cancer care. A distinguished scientist at the BC Cancer Research Institute (BCCRI) and professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC), Dr. Sorensen was selected based on his remarkable contributions to the field of pediatric cancer research and in translating scientific discoveries into clinical practice.
Congratulations to Lorenzo Lindo of Hay Lab (Terry Fox Laboratory) for receiving a Canadian Cancer Society (CCS) Research Training Award, with joint funding from the Terry Fox Research Institute (TFRI).
The award is tied to the project titled, "Engineering CAR-T Cells to Overcome Immune Suppression and Enhance Efficacy in Multiple Myeloma.”
We are excited to announce the recipients of round two of the inaugural BC Cancer Clinician Researcher Start Up Competition.
BC Cancer Clinician Researcher Start Up Competition 2024 recipients – Round 2
Alan Nichol (BC Cancer – Vancouver): Predicting upgrades from non-invasive core biopsy specimens to invasive ductal carcinoma in surgical specimens using histology-based DNA organization analysis
Dr. Katey Enfield is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC), and a Scientist in the Department of Integrative Oncology at the BC Cancer Research Institute (BCCRI). Dr. Enfield received her PhD from UBC under the supervision of Dr. Wan Lam, where she employed a multiomics approach to discover and characterize oncogenes and tumour suppressor genes.
Five BC Cancer researchers are 2024 recipients of the Michael Smith Health Research BC’s Scholar and Health Professional-Investigator competition, receiving new funding to conduct critical research, develop innovative treatments, and translate their findings into practices that benefit people across BC.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.